Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Ovarian Neoplasms

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 39 articles:
HTML format

Single Articles


    May 2008
  1. EVANS DG , Shenton A, Woodward E, Lalloo F, et al
    Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.
    BMC Cancer. 2008;8:155.
    PubMed     Related articles    Abstract available   Free Full Text


  2. OUELLET V , Zietarska M, Portelance L, Lafontaine J, et al
    Characterization of three new serous epithelial ovarian cancer cell lines.
    BMC Cancer. 2008;8:152.
    PubMed     Related articles    Abstract available   Free Full Text


  3. PYLKAS K , Erkko H, Nikkila J, Slyom S, et al
    Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.
    BMC Cancer. 2008;8:146.
    PubMed     Related articles    Abstract available   Free Full Text


  4. MACHACKOVA E , Foretova L, Lukesova M, Vasickova P, et al
    Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.
    BMC Cancer. 2008;8:140.
    PubMed     Related articles    Abstract available   Free Full Text


    April 2008
  5. BATISTA LI , Lu KH, Beahm EK, Arun BK, et al
    Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.
    BMC Cancer. 2008;8:101.
    PubMed     Related articles    Abstract available   Free Full Text


  6. JAKUBOWSKA A , Gronwald J, Menkiszak J, Gorski B, et al
    Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism.
    BMC Cancer. 2008;8:90.
    PubMed     Related articles    Abstract available   Free Full Text


    January 2008
  7. TETSCHE MS , Dethlefsen C, Pedersen L, Sorensen HT, et al
    The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort study.
    BMC Cancer. 2008;8:31.
    PubMed     Related articles    Abstract available   Free Full Text


  8. KUPRYJANCZYK J , Kraszewska E, Ziolkowska-Seta I, Madry R, et al
    TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.
    BMC Cancer. 2008;8:27.
    PubMed     Related articles    Abstract available   Free Full Text


  9. GEVAERT O , De Smet F, Van Gorp T, Pochet N, et al
    Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation.
    BMC Cancer. 2008;8:18.
    PubMed     Related articles    Abstract available   Free Full Text


  10. PRESS JZ , De Luca A, Boyd N, Young S, et al
    Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.
    BMC Cancer. 2008;8:17.
    PubMed     Related articles    Abstract available   Free Full Text


  11. VERMEIJ J , Teugels E, Bourgain C, Xiangming J, et al
    Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.
    BMC Cancer. 2008;8:3.
    PubMed     Related articles    Abstract available   Free Full Text


  12. TAKANO EA , Mitchell G, Fox SB, Dobrovic A, et al
    Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.
    BMC Cancer. 2008;8:59.
    PubMed     Related articles    Abstract available   Free Full Text


    December 2007
  13. ROCHET N , Jensen AD, Sterzing F, Munter MW, et al
    Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol.
    BMC Cancer. 2007;7:227.
    PubMed     Related articles    Abstract available   Free Full Text


  14. WILCOX CB , Feddes GO, Willet-Brozick JE, Hsu LC, et al
    Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer.
    BMC Cancer. 2007;7:223.
    PubMed     Related articles    Abstract available   Free Full Text


    November 2007
  15. YANG YC , Ho TC, Chen SL, Lai HY, et al
    Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line.
    BMC Cancer. 2007;7:216.
    PubMed     Related articles    Abstract available   Free Full Text


    August 2007
  16. MELICHAR B , Hyspler R, Dragounova E, Dvorak J, et al
    Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum.
    BMC Cancer. 2007;7:155.
    PubMed     Related articles    Abstract available   Free Full Text


  17. FRIEDENSON B
    The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers.
    BMC Cancer. 2007;7:152.
    PubMed     Related articles    Abstract available   Free Full Text


    July 2007
  18. TERAUCHI M , Kajiyama H, Shibata K, Ino K, et al
    Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
    BMC Cancer. 2007;7:140.
    PubMed     Related articles    Abstract available   Free Full Text


    June 2007
  19. AWADALLA AW , Ohaeri JU, Gholoum A, Khalid AO, et al
    Factors associated with quality of life of outpatients with breast cancer and gynecologic cancers and their family caregivers: a controlled study.
    BMC Cancer. 2007;7:102.
    PubMed     Related articles    Abstract available   Free Full Text


    April 2007
  20. SAMARITANI R , Corrado G, Vizza E, Sbiroli C, et al
    Cyclophosphamide metronomic chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
    BMC Cancer. 2007;7:65.
    PubMed     Related articles    Abstract available   Free Full Text


  21. GARCIA-CLOSAS M , Brinton LA, Lissowska J, Richesson D, et al
    Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study.
    BMC Cancer. 2007;7:60.
    PubMed     Related articles    Abstract available   Free Full Text


    January 2007
  22. KADOURI L , Bercovich D, Elimelech A, Lerer I, et al
    A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer.
    BMC Cancer. 2007;7:14.
    PubMed     Related articles    Abstract available   Free Full Text


  23. LIU Y , Xi L, Liao G, Wang W, et al
    Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2.
    BMC Cancer. 2007;7:22.
    PubMed     Related articles    Abstract available   Free Full Text


  24. KRYPUY M , Ahmed AA, Etemadmoghadam D, Hyland SJ, et al
    High resolution melting for mutation scanning of TP53 exons 5-8.
    BMC Cancer. 2007;7:168.
    PubMed     Related articles    Abstract available   Free Full Text


    September 2006
  25. DUROCHER F , Labrie Y, Soucy P, Sinilnikova O, et al
    Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    BMC Cancer. 2006;6:230.
    PubMed     Related articles    Abstract available   Free Full Text


  26. BAMIAS A , Papadimitriou C, Efstathiou E, Rodolakis A, et al
    Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: the experience of the Hellenic Cooperative Oncology Group.
    BMC Cancer. 2006;6:228.
    PubMed     Related articles    Abstract available   Free Full Text


    August 2006
  27. YANG HJ , Liu VW, Wang Y, Tsang PC, et al
    Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.
    BMC Cancer. 2006;6:212.
    PubMed     Related articles    Abstract available   Free Full Text


  28. PIGNATA S , Scambia G, Savarese A, Breda E, et al
    Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial (ClinicalTrials.gov Identifier: NCT00326456).
    BMC Cancer. 2006;6:202.
    PubMed     Related articles    Abstract available   Free Full Text


    July 2006
  29. HELLEMAN J , van Staveren IL, Dinjens WN, van Kuijk PF, et al
    Mismatch repair and treatment resistance in ovarian cancer.
    BMC Cancer. 2006;6:201.
    PubMed     Related articles    Abstract available   Free Full Text


  30. HONIG A , Rieger L, Kapp M, Krockenberger M, et al
    Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study.
    BMC Cancer. 2006;6:199.
    PubMed     Related articles    Abstract available   Free Full Text


  31. TETSCHE MS , Norgaard M, Pedersen L, Lash TL, et al
    Prognosis of ovarian cancer subsequent to venous thromboembolism: A nationwide Danish cohort study.
    BMC Cancer. 2006;6:189.
    PubMed     Related articles    Abstract available   Free Full Text


  32. SONNEMANN J , Gange J, Pilz S, Stotzer C, et al
    Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
    BMC Cancer. 2006;6:183.
    PubMed     Related articles    Abstract available   Free Full Text


  33. FERRANDINA G , Ranelletti FO, Martinelli E, Paglia A, et al
    Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer.
    BMC Cancer. 2006;6:182.
    PubMed     Related articles    Abstract available   Free Full Text


    June 2006
  34. INCIURA A , Simavicius A, Juozaityte E, Kurtinaitis J, et al
    Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients.
    BMC Cancer. 2006;6:153.
    PubMed     Related articles    Abstract available   Free Full Text


  35. HERATH NI , Spanevello MD, Sabesan S, Newton T, et al
    Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.
    BMC Cancer. 2006;6:144.
    PubMed     Related articles    Abstract available   Free Full Text


    April 2006
  36. NETINATSUNTHORN W , Hanprasertpong J, Dechsukhum C, Leetanaporn R, et al
    WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.
    BMC Cancer. 2006;6:90.
    PubMed     Related articles    Abstract available   Free Full Text


  37. ZAFRAKAS M , Petschke B, Donner A, Fritzsche F, et al
    Expression analysis of Mammaglobin A (SCGB2A2) and Lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
    BMC Cancer. 2006;6:88.
    PubMed     Related articles    Abstract available   Free Full Text


    March 2006
  38. CABIBI D , Martorana A, Cappello F, Barresi E, et al
    Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report.
    BMC Cancer. 2006;6:47.
    PubMed     Related articles    Abstract available


    June 2005
  39. NUNEZ MI , Rosen DG, Ludes-Meyers JH, Abba MC, et al
    WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.
    BMC Cancer 2005;5:64.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: